This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignees: Raptor Pharmaceutical Corp, Raptor Pharmaceuticals Inc.. Active years: 2010-2011.
Company Filing History:
Years Active: 2010-2011
Title: Joseph Yang: Innovator in Blood-Brain Barrier Transport
Introduction
Joseph Yang is a notable inventor based in Delta, California. He has made significant contributions to the field of biomedical research, particularly in the area of blood-brain barrier transport. With a total of 2 patents, his work focuses on enhancing the delivery of therapeutic agents to the central nervous system.
Latest Patents
Joseph Yang's latest patents include innovative compositions and methods for modulating blood-brain barrier transport. One of his inventions provides conjugates of therapeutic or active agents with melanotransferrin or other ligands of a melanotransferrin receptor. This invention outlines methods for screening and selecting such conjugates, ligands, and modulators both in vitro and in vivo. It also details the use of these conjugates, modulators, and ligands in diagnosing and treating diseases, particularly those affecting the central nervous system or related to lysosomal storage diseases. Another patent similarly focuses on compositions for modulating blood-brain barrier transport, emphasizing the importance of these conjugates and their potential therapeutic applications.
Career Highlights
Throughout his career, Joseph Yang has worked with prominent companies in the pharmaceutical industry, including Raptor Pharmaceuticals Inc. and Raptor Pharmaceutical Corp. His experience in these organizations has allowed him to develop and refine his innovative ideas, contributing to advancements in medical science.
Collaborations
Joseph has collaborated with esteemed colleagues such as Richard Beliveau and Michel Demeule. These partnerships have further enriched his research and development efforts in the field.
Conclusion
Joseph Yang's work in modulating blood-brain barrier transport represents a significant advancement in the treatment of central nervous system diseases. His innovative patents and collaborations highlight his commitment to improving therapeutic delivery methods.